Stay updated with breaking news from Precision Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene...
This randomized study examines the effect of higher-dose fluvoxamine on time to sustained recovery from mild to moderate COVID-19 or progression to severe disea
Cancer remains one of the most pressing public health challenges worldwide, affecting millions of lives and compounding economic burdens along the way. ...
- Precision Eligible to Receive up to $227 Million in Upfront Economics and Milestone Payments for Azer-Cel in Addition to Double-Digit Royalties on Sales- Imugene to Assume Control of Precision’s Cell Therapy Infrastructure in Pursuit of Biologics License Application for Azer-Cel in LBCL Patients who Relapse Follow...
DURHAM - A big licensing deal potentially worth hundreds of millions of dollars with an Austrlia-based company at the same time also has triggered what Precision Biosciences calls a "right-sized" organization of the company. "Prior to the announcement, we had 190 employees, with 110 going forward with Precision. Most of the 80 employees went with